For the quarter ending 2025-09-30, MRAI had $2,235K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from sale of business unit | 500 | 500 |
| Net cash provided by investing activities | 0 | 500 |
| Proceeds from issuance of convertible debentures (note 7) | 0 | 3,000 |
| Payments of debt issuance costs | 0 | 162 |
| Payments on convertible debentures (note 7) | 500 | 1,500 |
| Payments to seller for acquisition | 0 | 196 |
| Proceeds from issuances of common stock in private offerings, net | 2,101 | 730 |
| Proceeds from sale of future cash receipts on accounts receivable | 0 | 0 |
| Payments to buyer of receivables | 0 | 0 |
| Net cash provided by financing activities | 1,601 | 1,872 |
| Depreciation and amortization | 107 | 214 |
| Share-based compensation | 415 | 1,043 |
| Amortization of right-of-use asset | 14 | 31 |
| Non-cash interest | 448 | 914 |
| Amortization of debt premium and debt issuance costs, net | -8 | -17 |
| Issuance of common stock to vendors in exchange for services | 0 | 1,008 |
| Accounts receivable and unbilled receivables | -292 | 56 |
| Prepaid expenses and other assets | -130 | -176 |
| Accounts payable | 823 | 479 |
| Accrued expenses | -87 | -516 |
| Accrued fiduciary obligations | -2,148 | -871 |
| Operating lease liabilities | -60 | -123 |
| Other liabilities | -94 | 92 |
| Net loss | -3,460 | -7,440 |
| Loss on sale of receivables | 0 | 0 |
| Loss on sale of business unit | 0 | - |
| Impairment of goodwill and intangible assets | 0 | 0 |
| Net cash used in operating activities | 624 | -3,324 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 2,235 | -952 |
| Cash and cash equivalents at beginning of period | 9,232 | - |
| Cash and cash equivalents at end of period | 10,515 | - |
Marpai, Inc. (MRAI)
Marpai, Inc. (MRAI)